InsidersTradesSigma
Track the PHARMANUTRA CS - DEPOSITO DEL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2023 share price and the full directors' dealings record of the company, a listed equity based in Italy. Shares are listed on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA CS - DEPOSITO DEL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2023 has recorded 0 reports. Market capitalisation: €792.8m. The full history is openly available.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,548 of 29,064 companies
61.8
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.7x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Declarations0 total
No declarations found
0 of 0 declarations
About PHARMANUTRA CS - DEPOSITO DEL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2023
PHARMANUTRA CS is a company operating in the health and pharmaceutical sector, specializing in the development of nutraceutical products. It submitted its interim management report as of September 30, 2023, on the XMIL market.